Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
345
-
Total 13F shares, excl. options
-
68.7M
-
Shares change
-
+734K
-
Total reported value, excl. options
-
$8.48B
-
Value change
-
+$105M
-
Put/Call ratio
-
6.92
-
Number of buys
-
171
-
Number of sells
-
-132
-
Price
-
$123.47
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q3 2018
378 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q3 2018.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 345 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.7M shares
of 71.9M outstanding shares and own 95.47% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (8.94M shares), Vanguard Group Inc (7.07M shares), BlackRock Inc. (6.64M shares), FRANKLIN RESOURCES INC (4.84M shares), Neuberger Berman Group LLC (2.91M shares), STATE STREET CORP (2.36M shares), ALLIANCEBERNSTEIN L.P. (2.19M shares), JPMORGAN CHASE & CO (1.64M shares), BAMCO INC /NY/ (1.61M shares), and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.43M shares).
This table shows the top 345 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.